ABI, Caprion, Berlex, Novo Nordisk, Ciphergen, Nasdaq, GE Healthcare, Manipal AcuNova, Thermo, Clinical Data, Johns Hopkins | GenomeWeb

ABI Reports 4-Percent Revenue Growth in Fiscal Q2; Mass Spec Sales Grow 5 Percent

Applied Biosystems reported a 4-percent increase in total revenue for its second quarter of fiscal 2006, the company said this week.

ABI had total revenues of $481 million for the three months ended Dec. 31, 2005, compared to $463 million for same period one year ago. Revenue for its mass spectrometry segment grew 5 percent to $119 million year over year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.